Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Balance at Dec. 31, 2021 $ 85,218 $ 6 $ 548,870 $ (79) $ (463,579)
Balance (in shares) at Dec. 31, 2021   6,202,403      
Exercise of stock options, Shares   3,770      
Vesting of restricted stock units 1 $ 1      
Vesting of restricted stock units, Shares   73,956      
Stock-based compensation expense 2,863   2,863    
Other comprehensive loss (194)     (194)  
Net loss (25,146)       (25,146)
Balance at Mar. 31, 2022 62,742 $ 7 551,733 (273) (488,725)
Balance (in shares) at Mar. 31, 2022   6,280,129      
Balance at Dec. 31, 2022 $ 127,736 $ 20 685,847 102 (558,233)
Balance (in shares) at Dec. 31, 2022 20,263,116 20,263,116      
Exercise of stock options, Shares 0        
Vesting of restricted stock units, Shares   111,023      
Exercise of prefunded warrants, Shares   34,991      
Stock-based compensation expense $ 2,645   2,645    
Other comprehensive loss 161     161  
Net loss (23,789)       (23,789)
Balance at Mar. 31, 2023 $ 106,753 $ 20 $ 688,492 $ 263 $ (582,022)
Balance (in shares) at Mar. 31, 2023 20,409,130 20,409,130